BioNTech SE(BNTX.US)

Last Updated 19:00:00 ET
longbridge loading

European Equities Traded in the US as American Depositary Receipts Open Week Tracking Higher in Monday Trading

fidelity·
US
BNTX
-1.19%
US
DBVT
-1.28%
US
EVAX
-2.69%
fidelity·
US
BNTX
-1.19%
US
DBVT
-1.28%
US
EVAX
-2.69%

BioNTech Maps Oncology Push, $1B Buyback and Manufacturing Cuts at AGM

Market Beat·
US
BNTX
-1.19%
US
BBH
+0.68%
US
PBE
+0.11%
Market Beat·
US
BNTX
-1.19%
US
BBH
+0.68%
US
PBE
+0.11%

Duality Biotherapeutics Exercises U.S. Cost and Profit-Sharing Option for BioNTech ADC

Tip Ranks·
US
BNTX
-1.19%
US
IBB
+0.10%
US
ARKG
+0.04%
Tip Ranks·
US
BNTX
-1.19%
US
IBB
+0.10%
US
ARKG
+0.04%

Singapore maintains biomed strength with 60+ plants despite closures

Singapore Business Review·
US
BNTX
-1.19%
US
PFE
+1.30%
Singapore Business Review·
US
BNTX
-1.19%
US
PFE
+1.30%

European Stocks Decline in Thursday Trading; Investors Remain Cautious About Middle East Peace Prospects

Fidelity·
US
BNTX
-1.19%
UK
RDSB
0.00%
US
SHEL
-0.15%
Fidelity·
US
BNTX
-1.19%
UK
RDSB
0.00%
US
SHEL
-0.15%

BioNTech Board Authorizes $1 Bln ADS Repurchase Program

rttnews·
US
BNTX
-1.19%
US
IBBQ
+0.07%
US
XBI
-0.69%
rttnews·
US
BNTX
-1.19%
US
IBBQ
+0.07%
US
XBI
-0.69%

BNTX Stock News: BioNTech Announces Layoffs as Covid-19 Revenue Slides

Barchart Option·
US
BNTX
-1.19%
US
FBT
+0.54%
US
LABU
-2.35%
Barchart Option·
US
BNTX
-1.19%
US
FBT
+0.54%
US
LABU
-2.35%

<![CDATA[Pharmaceutical Executive Daily: BioNTech Reports 2026 First Quarter Results]]>

Pharmexec·
US
BNTX
-1.19%
US
LABU
-2.35%
Pharmexec·
US
BNTX
-1.19%
US
LABU
-2.35%
© 2026 Longbridge｜Disclaimer